简报：COVID-19 对急诊科药物过量诊断和县级药物过量死亡的影响。
Brief Report: The Impact of COVID-19 on Emergency Department Overdose Diagnoses and County Overdose Deaths.
机构信息
Department of Emergency Medicine, University of Louisville, Louisville, Kentucky.
出版信息
Am J Addict. 2021 Jul;30(4):330-333. doi: 10.1111/ajad.13148. Epub 2021 Mar 19.
Abstract
BACKGROUND AND OBJECTIVES
We sought to understand the impact of COVID-19 on emergency department (ED) overdoses and county coroner verified overdose deaths.
METHODS
Electronic medical health record and county coroner data were gathered and comparisons were made between three 16-week time periods. In the three time periods, 873 individuals had an overdose diagnosis in the ED and 440 individuals in the county died of drug overdose.
RESULTS
While total ED patient volume decreased substantially, the number of ED overdose patients increased between March 6 and June 25, 2020. Furthermore, during this same period, coroner data revealed an increase in overdose deaths.
CONCLUSION AND SCIENTIFIC SIGNIFICANCE
This preliminary evidence provides a key insight into the impact of COVID-19 on both overdose presentations to the ED and county overdose deaths. These results emphasize the critical need for increasing vigilance to prevent overdose by continuously developing and optimizing both accessible and quality treatment as we navigate through this pandemic and its ongoing effects on persons with substance use disorder. (Am J Addict 2021;00:00-00).
摘要
背景与目的
我们旨在了解 COVID-19 对急诊室（ED）药物过量和县级验尸官认定的药物过量死亡的影响。
方法
收集电子医疗健康记录和县级验尸官数据，并在三个 16 周的时间段内进行比较。在这三个时间段内，873 名患者在 ED 被诊断为药物过量，440 名患者在县因药物过量死亡。
结果
尽管急诊室患者总数大幅减少，但 2020 年 3 月 6 日至 6 月 25 日期间，ED 药物过量患者的数量有所增加。此外，在同一时期，验尸官数据显示药物过量死亡人数有所增加。
结论和科学意义
这初步证据提供了一个关键的见解，了解 COVID-19 对 ED 药物过量就诊和县级药物过量死亡的影响。这些结果强调了在我们应对这一大流行病及其对药物滥用者的持续影响时，需要持续提高警惕，以防止药物过量的重要性，不断开发和优化可及和高质量的治疗方法。
相似文献
1
Brief Report: The Impact of COVID-19 on Emergency Department Overdose Diagnoses and County Overdose Deaths.简报：COVID-19 对急诊科药物过量诊断和县级药物过量死亡的影响。
Am J Addict. 2021 Jul;30(4):330-333. doi: 10.1111/ajad.13148. Epub 2021 Mar 19.
2
Signal of increased opioid overdose during COVID-19 from emergency medical services data.从紧急医疗服务数据看 COVID-19 期间阿片类药物过量的信号增加。
Drug Alcohol Depend. 2020 Sep 1;214:108176. doi: 10.1016/j.drugalcdep.2020.108176. Epub 2020 Jul 10.
3
Impact of COVID-19 Pandemic on Drug Overdoses in Indianapolis.新冠疫情对印第安纳波利斯药物滥用的影响。
J Urban Health. 2020 Dec;97(6):802-807. doi: 10.1007/s11524-020-00484-0. Epub 2020 Oct 1.
4
Emergency Medical Services and Syndromic Surveillance: A Comparison With Traditional Surveillance and Effects on Timeliness.紧急医疗服务和症状监测：与传统监测的比较及其对及时性的影响。
Public Health Rep. 2021 Nov-Dec;136(1_suppl):72S-79S. doi: 10.1177/00333549211018673.
5
Overdose deaths before and during the COVID-19 pandemic in a US county.美国一县新冠大流行前后的过量用药死亡人数。
Front Public Health. 2024 May 27;12:1366161. doi: 10.3389/fpubh.2024.1366161. eCollection 2024.
6
Excess Fatal Overdoses in the United States During the COVID-19 Pandemic by Geography and Substance Type: March 2020-August 2021.美国 COVID-19 大流行期间按地理位置和物质类型划分的过量致命过量情况：2020 年 3 月至 2021 年 8 月。
Am J Public Health. 2024 Jun;114(6):599-609. doi: 10.2105/AJPH.2024.307618.
7
Impact of COVID-19 pandemic on emergency department substance use screens and overdose presentations.COVID-19 大流行对急诊科药物使用筛查和药物过量就诊的影响。
Am J Emerg Med. 2021 Dec;50:472-476. doi: 10.1016/j.ajem.2021.08.058. Epub 2021 Aug 26.
8
Heroin and fentanyl overdoses in Kentucky: Epidemiology and surveillance.肯塔基州的海洛因和芬太尼过量用药情况：流行病学与监测
Int J Drug Policy. 2017 Aug;46:120-129. doi: 10.1016/j.drugpo.2017.05.051. Epub 2017 Jul 18.
9
The impact of the national stay-at-home order on emergency department visits for suspected opioid overdose during the first wave of the COVID-19 pandemic.全国居家令对 COVID-19 大流行第一波期间疑似阿片类药物过量急诊就诊的影响。
Drug Alcohol Depend. 2021 Nov 1;228:108977. doi: 10.1016/j.drugalcdep.2021.108977. Epub 2021 Aug 28.
10
China White epidemic: an eastern United States emergency department experience.“中国白”疫情：美国东部急诊科的经历
Ann Emerg Med. 1991 Feb;20(2):158-64. doi: 10.1016/s0196-0644(05)81216-8.
引用本文的文献
1
Sociodemographic and clinical characteristics associated with overdose among patients with a substance-related diagnosis in the emergency department of Southern California.南加州急诊科有物质相关诊断的患者中与过量用药相关的社会人口学和临床特征。
Harm Reduct J. 2025 May 24;22(1):86. doi: 10.1186/s12954-025-01233-9.
2
Acute care pathway assessed through performance indicators during the COVID-19 pandemic in OECD countries (2020-2021): a scoping review.经合组织国家在2019-2021年新冠疫情期间通过绩效指标评估的急性护理途径：一项范围综述
BMC Emerg Med. 2024 Jan 26;24(1):19. doi: 10.1186/s12873-024-00938-7.
3
A qualitative study of people who use methamphetamine during the early COVID-19 pandemic to inform future ED harm reduction strategies.一项关于在新冠疫情早期使用甲基苯丙胺者的定性研究，以指导未来急诊科的减少伤害策略。
Int J Emerg Med. 2023 Apr 28;16(1):30. doi: 10.1186/s12245-023-00505-0.
4
Increases in overdoses during the COVID-19 pandemic.新冠疫情期间过量用药情况的增加。
Proc (Bayl Univ Med Cent). 2023 Feb 27;36(3):411-412. doi: 10.1080/08998280.2023.2180256. eCollection 2023.
5
Have Deaths of Despair Risen during the COVID-19 Pandemic? A Systematic Review.新冠大流行期间是否出现了“绝望致死”现象？一项系统综述。
Int J Environ Res Public Health. 2022 Oct 7;19(19):12835. doi: 10.3390/ijerph191912835.
6
Variability in Opioid-Related Drug Overdoses, Social Distancing, and Area-Level Deprivation during the COVID-19 Pandemic: a Bayesian Spatiotemporal Analysis.新冠大流行期间阿片类药物相关药物过量、社会隔离和区域贫困程度的变异性：贝叶斯时空分析。
J Urban Health. 2022 Oct;99(5):873-886. doi: 10.1007/s11524-022-00675-x. Epub 2022 Sep 6.
7
Has the United States Reached a Plateau in Overdoses Caused by Synthetic Opioids After the Onset of the COVID-19 Pandemic? Examination of Centers for Disease Control and Prevention Data to November 2021.在新冠疫情爆发后，美国由合成阿片类药物导致的过量用药情况是否已达到平稳状态？对疾病控制与预防中心截至2021年11月的数据进行的审查。
Front Psychiatry. 2022 Jul 7;13:947603. doi: 10.3389/fpsyt.2022.947603. eCollection 2022.
8
Impact of the COVID-19 pandemic on temporal patterns of mental health and substance abuse related mortality in Michigan: An interrupted time series analysis.2019年冠状病毒病大流行对密歇根州心理健康及药物滥用相关死亡率时间模式的影响：一项中断时间序列分析
Lancet Reg Health Am. 2022 Jun;10:100218. doi: 10.1016/j.lana.2022.100218. Epub 2022 Mar 6.
9
Impact of the COVID-19 Pandemic on Opioid Overdose Deaths: a Spatiotemporal Analysis.新冠疫情对阿片类药物过量死亡的影响：时空分析。
J Urban Health. 2022 Apr;99(2):316-327. doi: 10.1007/s11524-022-00610-0. Epub 2022 Feb 18.
本文引用的文献
1
An Analysis of Changes in Emergency Department Visits After a State Declaration During the Time of COVID-19.新冠疫情期间，国家宣布进入紧急状态后，对急诊科就诊人数变化的分析。
Ann Emerg Med. 2020 Nov;76(5):595-601. doi: 10.1016/j.annemergmed.2020.06.019. Epub 2020 Jun 11.
2
Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2).优化 COVID-19（SARS-CoV-2）期间阿片类药物使用障碍的药物治疗。
J Addict Med. 2020 Jul/Aug;14(4):e1-e3. doi: 10.1097/ADM.0000000000000678.
3
The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment.新型冠状病毒肺炎大流行及其对物质使用的影响：对预防和治疗的启示。
Psychiatry Res. 2020 Jul;289:113096. doi: 10.1016/j.psychres.2020.113096. Epub 2020 May 13.
4
Innovation During COVID-19: Improving Addiction Treatment Access.新冠疫情期间的创新：改善成瘾治疗的可及性。
J Addict Med. 2020 Jul/Aug;14(4):e8-e9. doi: 10.1097/ADM.0000000000000685.
5
Opioid Use Disorder and COVID-19: Crashing of the Crises.阿片类药物使用障碍与 COVID-19：危机的碰撞。
J Addict Med. 2020 Jul/Aug;14(4):e6-e7. doi: 10.1097/ADM.0000000000000684.
6
Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment.阿片类药物使用障碍和 COVID-19 大流行：呼吁维持监管放宽，并进一步扩大治疗机会。
Subst Abus. 2020;41(2):147-149. doi: 10.1080/08897077.2020.1752351.
7
Collision of the COVID-19 and Addiction Epidemics.新冠肺炎与成瘾流行病的碰撞。
Ann Intern Med. 2020 Jul 7;173(1):61-62. doi: 10.7326/M20-1212. Epub 2020 Apr 2.
8
Racial/Ethnic and Age Group Differences in Opioid and Synthetic Opioid-Involved Overdose Deaths Among Adults Aged ≥18 Years in Metropolitan Areas - United States, 2015-2017.大都市地区≥18 岁成年人中阿片类药物和合成阿片类药物相关过量死亡的种族/民族和年龄组差异 - 美国，2015-2017 年。
MMWR Morb Mortal Wkly Rep. 2019 Nov 1;68(43):967-973. doi: 10.15585/mmwr.mm6843a3.
Zotero 插件